English

Deciphera Pharmaceuticals, Inc.

EDGAR

DCPH Quarterly report (10-Q) · filed 2024-05-10

85 filing records in this dataset, filed from 2016-07-14 to 2024-05-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

45 million USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 44999000 USD Source

Operating margin

-108.55%

2024 Q1 · %

Exact inputs and evidence

Operating Income: -48847000 USD Source
Revenue: 44999000 USD Source

Operating cash flow

-54.6 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -54585000 USD Source

Free cash flow

-54.7 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -54585000 USD Source
Capital Expenditure: 146000 USD Source

Cash and cash equivalents: 91.2 million USD 2024-03-31 Source
Exact value

91228000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 82.2 million shares 2024-03-31 Source
Exact value

82158670 shares

Reported share-count change

4.65% · 3.65 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

78507752 shares · 2023-03-31· Source
82158670 shares · 2024-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

175 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Revenue: 38304000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 43313000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 163356000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 115062000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 44999000 USD · 2024-01-01 – 2024-03-31 Source

Net income

-190 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Net income: -48562000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -49581000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -194900000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -147800000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -45100000 USD · 2024-01-01 – 2024-03-31 Source

Operating cash flow

-152 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: -88081000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -49455000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -117888000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -88081000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -146697000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -117888000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -54585000 USD · 2024-01-01 – 2024-03-31 Source

Capital expenditure

564 thousand USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Capital expenditure: 653000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 360000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 715000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 653000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 778000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 715000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 146000 USD · 2024-01-01 – 2024-03-31 Source

Free cash flow

-152 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: -88081000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -49455000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -117888000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -88081000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -146697000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -117888000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -54585000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 653000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 360000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 715000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 653000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 778000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 715000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 146000 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-10.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2023-12-31
Operating income: 9 of 11 periods available· newest 2023-12-31
Net income: 9 of 11 periods available· newest 2023-12-31
Operating cash flow: 9 of 11 periods available· newest 2023-12-31
Capital expenditure: 9 of 11 periods available· newest 2023-12-31
Total assets: 8 of 11 periods available· newest 2023-12-31
Total liabilities: 8 of 11 periods available· newest 2023-12-31
Current assets: 8 of 11 periods available· newest 2023-12-31
Current liabilities: 8 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+21.9%

Prior period

USD 134.04 million

2022-01-01 – 2022-12-31
Current period

USD 163.36 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

163356000 − 134036000 = 29320000 USD

134036000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
163356000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Year-over-year change in Revenue: 29320000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 163356000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1409137 Filing: 000165415124000004 Input fundies:Revenue: 134036000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1409799 Filing: 000165415124000004
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 16 million

Prior period

−USD 178.9 million

2022-01-01 – 2022-12-31
Current period

−USD 194.9 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-194900000 − -178900000 = -16000000 USD

-178900000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-194900000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Year-over-year change in Net income: -16000000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -194900000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000018/dcph-20240331.htm#365322 Filing: 000165415124000018 Input fundies:NetIncome: -178900000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1629652 Filing: 000165415124000004
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.17 million

Prior period

−USD 152.86 million

2022-01-01 – 2022-12-31
Current period

−USD 146.7 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-146697000 − -152862000 = 6165000 USD

-152862000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-146697000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Year-over-year change in Operating cash flow: 6165000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -146697000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573014 Filing: 000165415124000004 Input fundies:OperatingCashFlow: -152862000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573678 Filing: 000165415124000004
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-7.5%

Prior period

USD 841,000

2022-01-01 – 2022-12-31
Current period

USD 778,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

778000 − 841000 = -63000 USD

841000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
778000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Year-over-year change in Capital expenditure: -63000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 778000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1581888 Filing: 000165415124000004 Input fundies:CapitalExpenditure: 841000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1582452 Filing: 000165415124000004
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 163.36 million 100% of revenue
Cost of revenue USD 3.73 million 2.3% of revenue
Operating expenses USD 370.58 million 227% of revenue
Operating income −USD 210.96 million −129% of revenue
Tax, interest and other Derived −USD 16.06 million −9.8% of revenue
Net income −USD 194.9 million −119% of revenue

Cash

Operating cash flow −USD 146.7 million −90% of revenue
Capital expenditure USD 778,000 0.5% of revenue
Free cash flow Derived −USD 147.48 million −90% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Operating loss: operating costs were 903% of revenue.
2020 Operating loss: operating costs were 744% of revenue.
2021 Operating loss: operating costs were 412% of revenue.
2022 Operating loss: operating costs were 236% of revenue.
2023 Operating loss: operating costs were 229% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	0	17610000 Derived	-17610000	2206000 Derived	-19816000	-13411000 Derived	Source 2015-01-01 – 2015-12-31: 0 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -17610000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -19816000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -13269000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 142000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	0	25838000 Derived	-25838000	102000 Derived	-25940000	-23313000 Derived	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -25838000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -25940000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -23090000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 223000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	50935000 Derived	-50935000	-635000 Derived	-50300000	-37108000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -50935000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -50300000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -36702000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 406000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	104099000 Derived	-104099000	-4199000 Derived	-99900000	-87908000 Derived	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -104099000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -99900000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -86783000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1125000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	25000000	225726000 Derived	-200726000	-8426000 Derived	-192300000	-154231000 Derived	Source 2019-01-01 – 2019-12-31: 25000000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -200726000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -192300000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -149296000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 4935000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	42087000	313277000 Derived	-271190000	-4690000 Derived	-266500000	-244999000 Derived	Source 2020-01-01 – 2020-12-31: 42087000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -271190000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -266500000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -239683000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5316000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	96148000	396225000 Derived	-300077000	-77000 Derived	-300000000	-242794000 Derived	Source 2021-01-01 – 2021-12-31: 96148000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -300077000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -300000000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -240824000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1970000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	134036000	316758000 Derived	-182722000	-3822000 Derived	-178900000	-153703000 Derived	Source 2022-01-01 – 2022-12-31: 134036000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -182722000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -178900000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -152862000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 841000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	163356000	374314000 Derived	-210958000	-16058000 Derived	-194900000	-147475000 Derived	Source 2023-01-01 – 2023-12-31: 163356000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -210958000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -194900000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -146697000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 778000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 163.4M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20192019-12-31	Revenue	25000000	Revenue: 25000000 Open source
20202020-12-31	Revenue	42087000	Revenue: 42087000 Open source
20212021-12-31	Revenue	96148000	Revenue: 96148000 Open source
20222022-12-31	Revenue	134036000	Revenue: 134036000 Open source
20232023-12-31	Revenue	163356000	Revenue: 163356000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

21.9% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 25000000 Open source Revenue: 0 Open source
20202020-12-31	Year over year	68.3%	Revenue: 42087000 Open source Revenue: 25000000 Open source
20212021-12-31	Year over year	128.5%	Revenue: 96148000 Open source Revenue: 42087000 Open source
20222022-12-31	Year over year	39.4%	Revenue: 134036000 Open source Revenue: 96148000 Open source
20232023-12-31	Year over year	21.9%	Revenue: 163356000 Open source Revenue: 134036000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -129.1% 2023

Net margin -119.3% 2023

Free cash flow margin -90.3% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	Not reported	Operating Income: -17610000 Open source Revenue: 0 Open source
20162016-12-31	Operating margin	Not reported	Operating Income: -25838000 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -50935000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -104099000 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	-802.9%	Operating Income: -200726000 Open source Revenue: 25000000 Open source
20202020-12-31	Operating margin	-644.4%	Operating Income: -271190000 Open source Revenue: 42087000 Open source
20212021-12-31	Operating margin	-312.1%	Operating Income: -300077000 Open source Revenue: 96148000 Open source
20222022-12-31	Operating margin	-136.3%	Operating Income: -182722000 Open source Revenue: 134036000 Open source
20232023-12-31	Operating margin	-129.1%	Operating Income: -210958000 Open source Revenue: 163356000 Open source
20152015-12-31	Net margin	Not reported	Net Income: -19816000 Open source Revenue: 0 Open source
20162016-12-31	Net margin	Not reported	Net Income: -25940000 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -50300000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -99900000 Open source Revenue: 0 Open source
20192019-12-31	Net margin	-769.2%	Net Income: -192300000 Open source Revenue: 25000000 Open source
20202020-12-31	Net margin	-633.2%	Net Income: -266500000 Open source Revenue: 42087000 Open source
20212021-12-31	Net margin	-312%	Net Income: -300000000 Open source Revenue: 96148000 Open source
20222022-12-31	Net margin	-133.5%	Net Income: -178900000 Open source Revenue: 134036000 Open source
20232023-12-31	Net margin	-119.3%	Net Income: -194900000 Open source Revenue: 163356000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -13269000 Open source Capital Expenditure: 142000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -23090000 Open source Capital Expenditure: 223000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -36702000 Open source Capital Expenditure: 406000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -86783000 Open source Capital Expenditure: 1125000 Open source
20192019-12-31	Free cash flow margin	-616.9%	Revenue: 25000000 Open source Operating Cash Flow: -149296000 Open source Capital Expenditure: 4935000 Open source
20202020-12-31	Free cash flow margin	-582.1%	Revenue: 42087000 Open source Operating Cash Flow: -239683000 Open source Capital Expenditure: 5316000 Open source
20212021-12-31	Free cash flow margin	-252.5%	Revenue: 96148000 Open source Operating Cash Flow: -240824000 Open source Capital Expenditure: 1970000 Open source
20222022-12-31	Free cash flow margin	-114.7%	Revenue: 134036000 Open source Operating Cash Flow: -152862000 Open source Capital Expenditure: 841000 Open source
20232023-12-31	Free cash flow margin	-90.3%	Revenue: 163356000 Open source Operating Cash Flow: -146697000 Open source Capital Expenditure: 778000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -146.7M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-13269000	Operating Cash Flow: -13269000 Open source
20162016-12-31	Operating cash flow	-23090000	Operating Cash Flow: -23090000 Open source
20172017-12-31	Operating cash flow	-36702000	Operating Cash Flow: -36702000 Open source
20182018-12-31	Operating cash flow	-86783000	Operating Cash Flow: -86783000 Open source
20192019-12-31	Operating cash flow	-149296000	Operating Cash Flow: -149296000 Open source
20202020-12-31	Operating cash flow	-239683000	Operating Cash Flow: -239683000 Open source
20212021-12-31	Operating cash flow	-240824000	Operating Cash Flow: -240824000 Open source
20222022-12-31	Operating cash flow	-152862000	Operating Cash Flow: -152862000 Open source
20232023-12-31	Operating cash flow	-146697000	Operating Cash Flow: -146697000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -147.5M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-13411000	Operating Cash Flow: -13269000 Open source Capital Expenditure: 142000 Open source
20162016-12-31	Free cash flow	-23313000	Operating Cash Flow: -23090000 Open source Capital Expenditure: 223000 Open source
20172017-12-31	Free cash flow	-37108000	Operating Cash Flow: -36702000 Open source Capital Expenditure: 406000 Open source
20182018-12-31	Free cash flow	-87908000	Operating Cash Flow: -86783000 Open source Capital Expenditure: 1125000 Open source
20192019-12-31	Free cash flow	-154231000	Operating Cash Flow: -149296000 Open source Capital Expenditure: 4935000 Open source
20202020-12-31	Free cash flow	-244999000	Operating Cash Flow: -239683000 Open source Capital Expenditure: 5316000 Open source
20212021-12-31	Free cash flow	-242794000	Operating Cash Flow: -240824000 Open source Capital Expenditure: 1970000 Open source
20222022-12-31	Free cash flow	-153703000	Operating Cash Flow: -152862000 Open source Capital Expenditure: 841000 Open source
20232023-12-31	Free cash flow	-147475000	Operating Cash Flow: -146697000 Open source Capital Expenditure: 778000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.9% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
20162016-12-31	Liabilities / assets	10.2%	Total Liabilities: 6038000 Open source Total Assets: 58945000 Open source
20172017-12-31	Liabilities / assets	7.6%	Total Liabilities: 15122000 Open source Total Assets: 199095000 Open source
20182018-12-31	Liabilities / assets	11.3%	Total Liabilities: 35578000 Open source Total Assets: 315559000 Open source
20192019-12-31	Liabilities / assets	12.2%	Total Liabilities: 75942000 Open source Total Assets: 622409000 Open source
20202020-12-31	Liabilities / assets	15.4%	Total Liabilities: 98756000 Open source Total Assets: 642432000 Open source
20212021-12-31	Liabilities / assets	29%	Total Liabilities: 124764000 Open source Total Assets: 429484000 Open source
20222022-12-31	Liabilities / assets	24.7%	Total Liabilities: 112348000 Open source Total Assets: 454039000 Open source
20232023-12-31	Liabilities / assets	25.9%	Total Liabilities: 122650000 Open source Total Assets: 473566000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.8× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	12.78×	Current Assets: 58252000 Open source Current Liabilities: 4557000 Open source
20172017-12-31	Current assets / current liabilities	14.35×	Current Assets: 198182000 Open source Current Liabilities: 13815000 Open source
20182018-12-31	Current assets / current liabilities	13.24×	Current Assets: 301037000 Open source Current Liabilities: 22743000 Open source
20192019-12-31	Current assets / current liabilities	9.88×	Current Assets: 593408000 Open source Current Liabilities: 60038000 Open source
20202020-12-31	Current assets / current liabilities	8.34×	Current Assets: 584031000 Open source Current Liabilities: 69992000 Open source
20212021-12-31	Current assets / current liabilities	3.5×	Current Assets: 339014000 Open source Current Liabilities: 96773000 Open source
20222022-12-31	Current assets / current liabilities	4.54×	Current Assets: 392958000 Open source Current Liabilities: 86469000 Open source
20232023-12-31	Current assets / current liabilities	3.8×	Current Assets: 381096000 Open source Current Liabilities: 100275000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 19.82 million Exact value Exact value: -19816000 USD 2015-01-01 – 2015-12-31: -19816000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2015-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -19816000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19816000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312518099539/dcph-20171231.xml#89758 Filing: 000119312518099539 The citation records this snapshot. The page link may show a newer release later.	−USD 13.27 million Exact value Exact value: -13269000 USD 2015-01-01 – 2015-12-31: -13269000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2015-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -13269000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13269000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312518099539/dcph-20171231.xml#88646 Filing: 000119312518099539 The citation records this snapshot. The page link may show a newer release later.	USD 142,000 Exact value Exact value: 142000 USD 2015-01-01 – 2015-12-31: 142000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2015-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 142000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 142000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312518099539/dcph-20171231.xml#90902 Filing: 000119312518099539 The citation records this snapshot. The page link may show a newer release later.	−USD 13.41 million Calculation and evidence -13269000 − 142000 USD Exact free cash flow: -13411000 USD 2015-01-01 – 2015-12-31: -13269000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 142000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2015-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -13411000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13269000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312518099539/dcph-20171231.xml#88646 Filing: 000119312518099539 Input fundies:CapitalExpenditure: 142000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312518099539/dcph-20171231.xml#90902 Filing: 000119312518099539 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 25.94 million Exact value Exact value: -25940000 USD 2016-01-01 – 2016-12-31: -25940000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2016-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -25940000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25940000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312519074791/dcph-20181231.xml#619164 Filing: 000119312519074791 The citation records this snapshot. The page link may show a newer release later.	−USD 23.09 million Exact value Exact value: -23090000 USD 2016-01-01 – 2016-12-31: -23090000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2016-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -23090000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23090000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312519074791/dcph-20181231.xml#618895 Filing: 000119312519074791 The citation records this snapshot. The page link may show a newer release later.	USD 223,000 Exact value Exact value: 223000 USD 2016-01-01 – 2016-12-31: 223000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2016-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 223000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 223000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312519074791/dcph-20181231.xml#620292 Filing: 000119312519074791 The citation records this snapshot. The page link may show a newer release later.	−USD 23.31 million Calculation and evidence -23090000 − 223000 USD Exact free cash flow: -23313000 USD 2016-01-01 – 2016-12-31: -23090000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 223000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2016-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -23313000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23090000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312519074791/dcph-20181231.xml#618895 Filing: 000119312519074791 Input fundies:CapitalExpenditure: 223000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000119312519074791/dcph-20181231.xml#620292 Filing: 000119312519074791 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 50.3 million Exact value Exact value: -50300000 USD 2017-01-01 – 2017-12-31: -50300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2017-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -50300000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50300000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415120000003/dcph-20191231.htm#2111889 Filing: 000165415120000003 The citation records this snapshot. The page link may show a newer release later.	−USD 36.7 million Exact value Exact value: -36702000 USD 2017-01-01 – 2017-12-31: -36702000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2017-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -36702000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36702000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415120000003/dcph-20191231.htm#1984748 Filing: 000165415120000003 The citation records this snapshot. The page link may show a newer release later.	USD 406,000 Exact value Exact value: 406000 USD 2017-01-01 – 2017-12-31: 406000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2017-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 406000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 406000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415120000003/dcph-20191231.htm#2004052 Filing: 000165415120000003 The citation records this snapshot. The page link may show a newer release later.	−USD 37.11 million Calculation and evidence -36702000 − 406000 USD Exact free cash flow: -37108000 USD 2017-01-01 – 2017-12-31: -36702000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 406000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2017-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -37108000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36702000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415120000003/dcph-20191231.htm#1984748 Filing: 000165415120000003 Input fundies:CapitalExpenditure: 406000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415120000003/dcph-20191231.htm#2004052 Filing: 000165415120000003 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 99.9 million Exact value Exact value: -99900000 USD 2018-01-01 – 2018-12-31: -99900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2018-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -99900000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -99900000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000003/dcph-20201231.htm#1748761 Filing: 000165415121000003 The citation records this snapshot. The page link may show a newer release later.	−USD 86.78 million Exact value Exact value: -86783000 USD 2018-01-01 – 2018-12-31: -86783000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2018-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -86783000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -86783000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000003/dcph-20201231.htm#1656757 Filing: 000165415121000003 The citation records this snapshot. The page link may show a newer release later.	USD 1.13 million Exact value Exact value: 1125000 USD 2018-01-01 – 2018-12-31: 1125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2018-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 1125000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1125000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000003/dcph-20201231.htm#1670220 Filing: 000165415121000003 The citation records this snapshot. The page link may show a newer release later.	−USD 87.91 million Calculation and evidence -86783000 − 1125000 USD Exact free cash flow: -87908000 USD 2018-01-01 – 2018-12-31: -86783000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2018-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -87908000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -86783000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000003/dcph-20201231.htm#1656757 Filing: 000165415121000003 Input fundies:CapitalExpenditure: 1125000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000003/dcph-20201231.htm#1670220 Filing: 000165415121000003 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 192.3 million Exact value Exact value: -192300000 USD 2019-01-01 – 2019-12-31: -192300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2019-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -192300000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -192300000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415122000003/dcph-20211231.htm#1714768 Filing: 000165415122000003 The citation records this snapshot. The page link may show a newer release later.	−USD 149.3 million Exact value Exact value: -149296000 USD 2019-01-01 – 2019-12-31: -149296000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2019-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -149296000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -149296000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415122000003/dcph-20211231.htm#1621279 Filing: 000165415122000003 The citation records this snapshot. The page link may show a newer release later.	USD 4.94 million Exact value Exact value: 4935000 USD 2019-01-01 – 2019-12-31: 4935000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2019-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 4935000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4935000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415122000003/dcph-20211231.htm#1634883 Filing: 000165415122000003 The citation records this snapshot. The page link may show a newer release later.	−USD 154.23 million Calculation and evidence -149296000 − 4935000 USD Exact free cash flow: -154231000 USD 2019-01-01 – 2019-12-31: -149296000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 4935000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2019-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -154231000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -149296000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415122000003/dcph-20211231.htm#1621279 Filing: 000165415122000003 Input fundies:CapitalExpenditure: 4935000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415122000003/dcph-20211231.htm#1634883 Filing: 000165415122000003 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 266.5 million Exact value Exact value: -266500000 USD 2020-01-01 – 2020-12-31: -266500000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2020-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -266500000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -266500000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415123000003/dcph-20221231.htm#1727052 Filing: 000165415123000003 The citation records this snapshot. The page link may show a newer release later.	−USD 239.68 million Exact value Exact value: -239683000 USD 2020-01-01 – 2020-12-31: -239683000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2020-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -239683000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -239683000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415123000003/dcph-20221231.htm#1646199 Filing: 000165415123000003 The citation records this snapshot. The page link may show a newer release later.	USD 5.32 million Exact value Exact value: 5316000 USD 2020-01-01 – 2020-12-31: 5316000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2020-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 5316000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5316000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415123000003/dcph-20221231.htm#1659663 Filing: 000165415123000003 The citation records this snapshot. The page link may show a newer release later.	−USD 245 million Calculation and evidence -239683000 − 5316000 USD Exact free cash flow: -244999000 USD 2020-01-01 – 2020-12-31: -239683000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5316000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2020-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -244999000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -239683000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415123000003/dcph-20221231.htm#1646199 Filing: 000165415123000003 Input fundies:CapitalExpenditure: 5316000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415123000003/dcph-20221231.htm#1659663 Filing: 000165415123000003 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 300 million Exact value Exact value: -300000000 USD 2021-01-01 – 2021-12-31: -300000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2021-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -300000000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -300000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1629839 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	−USD 240.82 million Exact value Exact value: -240824000 USD 2021-01-01 – 2021-12-31: -240824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2021-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -240824000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -240824000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1574343 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	USD 1.97 million Exact value Exact value: 1970000 USD 2021-01-01 – 2021-12-31: 1970000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2021-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 1970000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1970000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1583017 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	−USD 242.79 million Calculation and evidence -240824000 − 1970000 USD Exact free cash flow: -242794000 USD 2021-01-01 – 2021-12-31: -240824000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1970000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2021-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -242794000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -240824000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1574343 Filing: 000165415124000004 Input fundies:CapitalExpenditure: 1970000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1583017 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 178.9 million Exact value Exact value: -178900000 USD 2022-01-01 – 2022-12-31: -178900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2022-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -178900000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -178900000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1629652 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	−USD 152.86 million Exact value Exact value: -152862000 USD 2022-01-01 – 2022-12-31: -152862000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2022-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -152862000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -152862000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573678 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	USD 841,000 Exact value Exact value: 841000 USD 2022-01-01 – 2022-12-31: 841000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2022-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 841000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 841000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1582452 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	−USD 153.7 million Calculation and evidence -152862000 − 841000 USD Exact free cash flow: -153703000 USD 2022-01-01 – 2022-12-31: -152862000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 841000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2022-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -153703000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -152862000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573678 Filing: 000165415124000004 Input fundies:CapitalExpenditure: 841000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1582452 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 194.9 million Exact value Exact value: -194900000 USD 2023-01-01 – 2023-12-31: -194900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Net Income: -194900000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -194900000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000018/dcph-20240331.htm#365322 Filing: 000165415124000018 The citation records this snapshot. The page link may show a newer release later.	−USD 146.7 million Exact value Exact value: -146697000 USD 2023-01-01 – 2023-12-31: -146697000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Operating Cash Flow: -146697000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -146697000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573014 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	USD 778,000 Exact value Exact value: 778000 USD 2023-01-01 – 2023-12-31: 778000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Capital Expenditure: 778000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 778000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1581888 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.	−USD 147.48 million Calculation and evidence -146697000 − 778000 USD Exact free cash flow: -147475000 USD 2023-01-01 – 2023-12-31: -146697000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 778000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Deciphera Pharmaceuticals, Inc. · 2023-12-31 Deciphera Pharmaceuticals, Inc. (edgar:1654151) Free cash flow: -147475000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:46:13Z Snapshot: 92889c84b0145a68f0d23a928b90fa26d42f2267ebeca6b8f5b6826983f04e34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1654151?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -146697000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1573014 Filing: 000165415124000004 Input fundies:CapitalExpenditure: 778000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415124000004/dcph-20231231.htm#1581888 Filing: 000165415124000004 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 1,935 latest values · 1,935 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001654151, 1654151, DCPH, edgar:1654151

Also known as DECIPHERA PHARMACEUTICALS, INC., Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals, LLC

Deciphera Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation